Snoring is a common sleep-related issue that can disrupt the snorer's and partner's sleep. It is caused by an obstruction in the airway that leads to irregular breathing and vibrations in the surrounding tissues, producing audible sounds. Factors such as nasal blockage, obesity, sleeping posture, and anatomical attributes contribute to snoring. Snoring can cause disturbed sleep patterns and may occur intermittently due to allergies or a severe cold.
Global Anti-Snoring Devices Market Trends
The rising aging prevalence: According to a WHO source, the number of people aged 60 and older has surpassed the number of children under five years old globally. By 2030, one in six people worldwide will be 60 years or over. Additionally, by 2050, the world’s population of people aged 60 and older will double to nearly 2.1 billion. Aging can cause sleep problems like snoring and sleep apnea in elderly individuals.Growing Funding for Research and development: According to the National Institute of Health, Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC), May 2022 update, the spending on R&D in the United States for sleep research was USD 493 million last year and USD 515 million this year. The government grant for sleep research is expected to boost market growth by creating opportunities for market players to develop innovative devices for managing and treating sleep-related diseases.
Increasing Awareness about Snoring: Rise in awareness among individuals about the impact of snoring on sleep quality and overall health. Public health campaigns have been launched to raise awareness about snoring and its health risks. Organizations like AASM and BSSAA have conducted awareness campaigns through online resources, social media, and community events. National Stop Snoring Week is an annual UK campaign dedicated to educating the public about snoring and its impact on sleep health.In Feb 2023, the 'More than a Snore' campaign was launched to raise awareness of sleep apnea, funded by a CDC grant awarded to the American Academy of Sleep Medicine.
Technological advancements and New product launches: Companies develop creative solutions through healthcare professional collaboration, and technology. Telemedicine and remote patient monitoring have increased the potential of the anti-snoring market by providing virtual consultations and care.
1. ProSomnus EVO [PH] Sleep and Snore Device received 510(k) clearance from the FDA in November 2022.
2. Oct 2022, Acurable secured €11 million to globally amplify it’s at home sleep apnea testing product, allowing convenient diagnosis of sleep apnea from home.
3. Illusion Aligners launched an innovative anti-snoring device in May 2022. The oral device is practical and comfortable and ensures peaceful sleep.
United States Anti-Snoring Devices Market
The surge in the U.S. antisnoring device market is fuelled by growing weight problems, easy access to online and offline merchandise, and technological improvements, driven by a tremendous populace dealing with loud snoring troubles. The Centers for Disease Control and Prevention reports that short sleep duration is prevalent in the United States, with 34% in females and 35.8% in males. The global prevalence of obstructive sleep apnea was reported to be 22.6% in December 2021. High demand for CPAP devices is driven by the need to treat obstructive sleep apnea, resulting in growth in the market segment.Anti-Snoring Devices Market Company Analysis
Koninklijke Philips N.V., ResMed, Inc., SomnoMed Limited, GSK Plc, Apnea Sciences Corporation, ZQuiet (Sleeping Well, LLC), Airway Management, Inc., Fisher & Paykel Healthcare Limited., and Tomed GmbH are the major players in the global anti-snoring devices market.Anti-Snoring Devices Market Company News
- Kickstarter Sleepmi Tech is seeking funds in August 2023 for the Sleepmi Z3, an intelligent gadget that helps prevent snoring and improves sleep quality.
- In May 2023, Illusion Aligners introduced an innovative, easy-to-wear, comfortable, and practical oral anti-snoring device that enhances users' sleep experiences.
- Mindray announced in December 2022 the launch of a new wearable patient monitoring device called the mWear system. This device is designed to track vital signs and improve patient care and workflow.
- In July 2022, Glidewell launched a new device called Silent Nite Sleep Appliance with Glidewell Hinge, which treats snoring and obstructive sleep apnea.
- Illusion Aligners launched an anti-snoring device (ASD) in June 2022 that is user-friendly, efficient, and comfortable to wear.
- February 2021, The FDA approved a device developed by Signifier Medical Technologies to reduce snoring and mild obstructive sleep apnea in patients 18 and older.
Products - Market breakup in 6 viewpoints:
1. Oral Appliances2. Nasal Devices
3. Tongue-Stabilizing Devices
4. Chin Straps
5. Position Control Devices
6. Expiratory Positive Airway Pressure (EPAP) Therapy Devices
Distribution Channels - Market breakup in 2 viewpoints:
1. Retail Pharmacies2. Online Stores
End-Users - Market breakup in 2 viewpoints:
1. Homecare2. Others
Country - Market breakup of 25 Countries:
1. North America1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
All the key players have been covered from 3 viewpoints:
- Overview
- Recent Development
- Revenue Analysis
Company Analysis:
1. Koninklijke Philips N.V.2. ResMed, Inc.
3. SomnoMed Limited
4. GSK Plc
5. Apnea Sciences Corporation
6. ZQuiet (Sleeping Well, LLC)
7. Airway Management, Inc.
8. Fisher & Paykel Healthcare Limited.
9. Tomed GmbH
Table of Contents
Companies Mentioned
- Koninklijke Philips N.V.
- ResMed, Inc.
- SomnoMed Limited
- GSK Plc
- Apnea Sciences Corporation
- ZQuiet (Sleeping Well, LLC)
- Airway Management, Inc.
- Fisher & Paykel Healthcare Limited.
- Tomed GmbH
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 1.55 Billion |
| Forecasted Market Value ( USD | $ 3.11 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
